{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:44:53Z","timestamp":1784072693377,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jtos.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T11:17:47Z","timestamp":1554117467000},"page":"565-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Oral guaifenesin for treatment of filamentary keratitis: A pilot study"],"prefix":"10.1016","volume":"17","author":[{"given":"Giulia","family":"Coco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Amparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Foulsham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena Tatiana","family":"Carreno-Galeano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Stockslager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Ciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2019.03.008_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1529-1839(05)70252-9","article-title":"A case report and review of filamentary keratitis","volume":"76","author":"Diller","year":"2005","journal-title":"Optometry"},{"key":"10.1016\/j.jtos.2019.03.008_bib2","first-page":"446","article-title":"Botulinum toxin injection for the management of refractory filamentary keratitis","volume":"130","author":"Gumus","year":"2012","journal-title":"Arch Ophthalmol (Chicago, Ill 1960"},{"key":"10.1016\/j.jtos.2019.03.008_bib3","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1167\/iovs.08-2938","article-title":"Investigation of the corneal filament in filamentary keratitis","volume":"50","author":"Tanioka","year":"2009","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.008_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archopht.1985.01050080090028","article-title":"The histopathology of filamentary keratitis","volume":"103","author":"Zaidman","year":"1985","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"key":"10.1016\/j.jtos.2019.03.008_bib5","first-page":"260","article-title":"Filamentary keratitis","volume":"95","author":"Wright","year":"1975","journal-title":"Trans Ophthalmol Soc U K"},{"key":"10.1016\/j.jtos.2019.03.008_bib6","article-title":"Investigation of the clinical features in filamentary keratitis in Hangzhou, east of China","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jtos.2019.03.008_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00006324-200306000-00007","article-title":"Management of filamentary keratitis associated with aqueous-deficient dry eye","volume":"80","author":"Albietz","year":"2003","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2019.03.008_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1442-9071.2003.00633.x","article-title":"Blink-related microtrauma: when the ocular surface harms itself","volume":"31","author":"Cher","year":"2003","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.008_bib9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00003226-199711000-00002","article-title":"The Castroviejo Lecture. Prolonged eyelid closure is a risk to the cornea","volume":"16","author":"Baum","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.03.008_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3109\/01902148.2011.623116","article-title":"Effect of guaifenesin on mucin production, rheology, and mucociliary transport in differentiated human airway epithelial cells","volume":"37","author":"Seagrave","year":"2011","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.jtos.2019.03.008_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00010.2005","article-title":"Respiratory tract mucin genes and mucin glycoproteins in Health and disease","volume":"86","author":"Rose","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jtos.2019.03.008_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/MLG.0b013e3180383651","article-title":"Upper airway mucin gene expression: a review","volume":"117","author":"Ali","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jtos.2019.03.008_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/end.1999.13.665","article-title":"Guaifenesin- and ephedrine-induced stones","volume":"13","author":"Assimos","year":"1999","journal-title":"J Endourol"},{"key":"10.1016\/j.jtos.2019.03.008_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jemermed.2014.01.022","article-title":"Acute renal failure after ingestion of guaifenesin and dextromethorphan","volume":"47","author":"Small","year":"2014","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jtos.2019.03.008_bib15","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"10.1016\/j.jtos.2019.03.008_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease Index","volume":"118","author":"Schiffman","year":"1960","journal-title":"Arch Ophthalmol (Chicago, Ill"},{"key":"10.1016\/j.jtos.2019.03.008_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1701632","article-title":"Airway mucin concentration as a marker of chronic bronchitis","volume":"377","author":"Kesimer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2019.03.008_bib18","first-page":"CD001287","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtos.2019.03.008_bib19","doi-asserted-by":"crossref","DOI":"10.4081\/mrm.2017.260","article-title":"Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections","volume":"12","author":"Albrecht","year":"2017","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.jtos.2019.03.008_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1465-9921-13-98","article-title":"Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells","volume":"13","author":"Seagrave","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.jtos.2019.03.008_bib21","doi-asserted-by":"crossref","unstructured":"Koh JW, Yang YR. Topical N\u2010acetylcystein on patients with refractory filamentary keratitis. Acta Ophthalmol n.d.;94. https:\/\/doi.org\/10.1111\/J.1755-3768.2016.0280.","DOI":"10.1111\/j.1755-3768.2016.0280"},{"key":"10.1016\/j.jtos.2019.03.008_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bjo.52.4.310","article-title":"Acetylcysteine in kerato-conjunctivitis sicca","volume":"52","author":"Absolon","year":"1968","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.008_bib23","first-page":"165","article-title":"[New trial treatment of dry eye with acetylcysteine ophthalmic solution]","volume":"77","author":"Haut","year":"1977","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.jtos.2019.03.008_bib24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/MLG.0b013e31817b0732","article-title":"Effect of steroids, acetyl-cysteine and calcium-activated chloride channel inhibitors on allergic mucin expression in sinus mucosa","volume":"118","author":"Hauber","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jtos.2019.03.008_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000322837","article-title":"Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea","volume":"87","author":"Kitano","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.jtos.2019.03.008_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.toxlet.2016.11.023","article-title":"Laryngeal mucus hypersecretion is exacerbated after smoking cessation and ameliorated by glucocorticoid administration","volume":"265","author":"Ueha","year":"2017","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jtos.2019.03.008_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2147\/OPTH.S162203","article-title":"Treatment outcomes in the DRy eye amniotic membrane (DREAM) study","volume":"12","author":"McDonald","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2019.03.008_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00003226-200003000-00005","article-title":"Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis","volume":"19","author":"Avisar","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.03.008_bib29","first-page":"926","article-title":"The beneficial effect of diclofenac sodium in the treatment of filamentary keratitis","volume":"119","author":"Grinbaum","year":"2001","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"key":"10.1016\/j.jtos.2019.03.008_bib30","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/ICL.0000000000000217","article-title":"Treatment of refractory filamentary keratitis with autologous serum tears","volume":"43","author":"Read","year":"2017","journal-title":"Eye Contact Lens Sci Clin Pract"},{"key":"10.1016\/j.jtos.2019.03.008_bib31","first-page":"693","article-title":"[Eyelid surgery for refractory filamentary keratitis]","volume":"115","author":"Kitazawa","year":"2011","journal-title":"Nihon Ganka Gakkai Zasshi"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201241930031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201241930031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:36:12Z","timestamp":1761539772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154201241930031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S154201241930031X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2019.03.008","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral guaifenesin for treatment of filamentary keratitis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}